CAC
AXNX

Cowen and Company’s Axonics, Inc. Common Stock AXNX Stock Holding History

Cowen and Company’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,001
Closed -$605K – 707
2024
Q2 		$605K Buy
+9,001
New +$606K 0.02% 169

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cowen and Company's AXNX Position: Q3 2024 in Review

Cowen and Company sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2024, closing a stake of 9,001 shares — an estimated $605K sold.

Cowen and Company first reported a position in AXNX in Q2 2024 and held it in 1 quarter. The position peaked at $605K in Q2 2024. 233 funds tracked by Wall St. Rank hold AXNX as of Q3 2024.

  • Cowen and Company reported no remaining Axonics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Cowen and Company sold 9,001 Axonics, Inc. Common Stock shares in Q3 2024, an estimated $605K.
  • Cowen and Company first reported a position in Axonics, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Cowen and Company's Axonics, Inc. Common Stock position peaked at $605K in Q2 2024.
  • 233 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2024.

Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.